header logo image


Page 31«..1020..30313233..4050..»

Archive for the ‘Stem Cell Therapy’ Category

Stem Cell Professionals: Stem Cell Therapy in York, Pa

Saturday, February 18th, 2017

Knee Pain

Knee pain, often caused by sport injuries, is incredibly common. If your knee pain is getting worse learn how you can stay out of surgery with Stem Cell Therapy.

The hip joint is the largest joint in the human body but this joint isn't indestructible. Over time and overuse joint pain can occur. Click to learn how you can be treated with Stem Cell Therapy.

Shoulder pain is typically a result from previous injury to the shoulder joint or tendons. Click to see how Stems Cell Therapy can help.

Plantar Fasciitis is one of the most common types of heel pain. The pain you experience during plantar fasciitis is actually inflammation in a ligament in your foot. This inflammation is commonly treated with stem cell therapy.

The lower back is a problematic area for many older adults. This part of the body is a very complex and interconnected network of muscles, discs, nerves and bones that can cause a number of problems that range from arthritis to muscle spasms.

Elbow joints are much less prone to wear and tear as other joints but pain is typically a result from years of repetitive motion. Click to see how we can help with Stem Cell Therapy.

Wrist pain is a common complaint. It's typically caused by sudden impacts and repetitive stress. Check out how Stem Cell therapy can alleviate your pain.

Like other joints injury and overuse are the typical causes of ankle pain. However, gout and joint space are among other causes. Click to see how you can benefit from Stem Cells.

Your neck or cervical spine is another problem area for many people. Like the lower back the neck is made up of discs, bones, muscles and ligaments which can cause people to experience many painful symptoms.

Read the rest here:
Stem Cell Professionals: Stem Cell Therapy in York, Pa

Read More...

Stem cell therapy adds pep to pets – Columbus Telegram

Saturday, February 18th, 2017

COLUMBUS For the past year, Dr. Todd Paczosa has been practicing what he calls the future of medicine.

The veterinarian treats his four-legged patients through stem cell therapy.

Im not anti-antibiotic, anti-medicine. I just believe that even in the future of cancer treatment that it is going to come down to your body healing itself, Paczosa said.

The process involves removing fatty tissue from a patient, extracting stem cells, then injecting the cells back into the animal's joints to promote healing.

Paczosa said he researched the treatment for about a decade before deciding to offer it at Redstone Veterinary Hospital in Columbus.

Our body is full of cells that heal. You get cut, your body heals. What we are doing is taking those cells, waking them up and saying, Hey, lets go to work, he said.

Since he started offering stem cell therapy last March, 17 dogs, horses and cattle have used the treatment. One of those patients is Butch, a 9-year-old schnauzer owned by Marge Biester of Columbus that was suffering from a strained ligament and achy joints.

He was really hurting. I had to do something for him, Biester said, adding that Butch wasnt putting much weight on his back leg when he walked.

The treatment was done in January. Butch was put under anesthesia to retrieve the fat tissue. Using equipment in-house, the stem cells were extracted and injected back into the dog that same day.

Paczosa, who has been a veterinarian for 23 years, said the entire process can be done in a day.

Biester noticed results in about two weeks.Butch wasnt doing his three-legged walk anymore and began acting like a more-active, younger version of himself.

Im amazed at how quickly he recovered, she said.

Paczosa said all of the animals he has treated so far have shown improvement.

One of these days, we will have one that doesnt work. Thats just medicine, but we havent had one yet, he said.

The possibility of the stem cell therapy not working can be a turnoff for some pet owners who might find it difficult to spend $1,900 to $2,400 for the treatment at Redstone. If it does work, Paczosa said the therapy is less expensive in the long run than putting an animal on medication for extended periods of time to ease the pain from arthritis.

Other pluses, he said, are that the regenerative therapy isnt as invasive as surgery and anti-rejection drugs don't have to be used since the cells come from the same animal.More than one joint can also be treated at a time and it can eliminate the use of non-steroidal anti-inflammatory drugs.

The biggest risks are putting the animal under anesthesia and infection of the surgical site where the fatty tissue is removed, typically from the shoulder area or abdomen.

Stem cell therapy is practiced at a few hundred veterinary clinics in the country. Redstone works with the animal stem cell company MediVet Biologics and uses that companys in-house technology.

Paczosa said owners have come from other states to use the therapy at his Columbus clinic.

Initial results from the procedure lasts about two years. An option to bank stem cells from a pet is available. A portion of what is taken can be stored in a lab and used again in the future.

For Paczosa's patients, results have been quick and ongoing.

Most owners have seen a dramatic improvement in two weeks. Our first patient is still seeing improvements, he said.

Read more here:
Stem cell therapy adds pep to pets - Columbus Telegram

Read More...

Stem Cell Therapy – Premier Regenerative Stem Cell

Saturday, February 18th, 2017

The Re-Brand Premier Regenerative Stem Cell and Wellness Centers, recently rebranded their business from Premier Stem Cell Institute, in response to expanding locations, technology, and treatments. This move reflects the growth and success this company has undergone recently and goals for the future.

PRSC and Wellness Centers President, Kandace Stolz said, This rebrand is the culmination of the years of work weve put into stem cell medicine. Were growing and healing more patients than we ever have before, this new name reflects those accomplishments and gives us room grow. We are so thrilled for this move and cant wait to do even more for our patients going forward.

Premier Regenerative Stem Cell and Wellness Centers will continue to partner with the NFL Alumni Association and treat current and former professional athletes. PRSC remains dedicated to studying stem cell treatment by collecting and tracking data to further stem cell progress and maximize results for all patients. PRSCs commitment to being a leader in stem cell and regenerative medicine is unwavering and will continue to innovate and learn to heal and improve the quality of life for all patients.

About Premier Regenerative Stem Cell and Wellness Centers: PRSC is a leading research and treatment facility in Colorado, providing innovative medicine and therapies for those in pain by harnessing the bodys own natural healing power of stem cells. As team of cutting-edge medical experts, PRSC is dedicated to treating patients by using their own stem cells to heal, improve quality of life, and battle the acute pain of chronic illnesses. Premier Regenerative Stem Cell and Wellness Center locations include Loveland Colorado, Dallas Texas, St. Louis, Missouri, and Jacksonville, Florida. PRSC has plans to expand to other major cities across the United States in the near future.

See the original post here:
Stem Cell Therapy - Premier Regenerative Stem Cell

Read More...

Takeda, TiGenix stem cell therapy shows sustained effect – FierceBiotech

Friday, February 17th, 2017

Takeda and TiGenix have presented 52-week data on their allogeneic expanded adipose-derived stem cells in Crohns disease patients with treatment-refractory complex perianal fistulas. The data show the Cx601 stem cells continue to outperform placebo one year after administration.

TiGenix presented the 24-week data from the successful phase 3 trial back in 2015, sparking a surge in its stock price and setting it up to land a deal with Takeda. Last year it followed up with the release of a first look at 52-week results confirming the efficacy outcomes seen in the earlier data drop.

Takeda and TiGenix have now shared another overview of the 52-week data at the 12th Congress of the European Crohns and Colitis Organisation (ECCO). The abstract includes treatment-related adverse event data that were absent from TiGenixs original release, but included in subsequent presentations.

Those 52-week data confirm the positive safety profile seen in the 24-week results. The rate of treatment-emergent adverse events was lower in the Cx601 cohort than the placebo plus standard of care arm at both time points. The same is true when only serious adverse events are analyzed.

The safety results complement the previously-released efficacy data. Among the 62% of patients who completed the 52-week follow-up, the results were comparable to those generated after 24 weeks. In the Cx601 arm, 56.3% of the modified intention-to-treat (mITT) population achieved combined remission after 52 weeks, compared to 51.5% after 24 weeks. The respective figures for the placebo cohort are 38.6% and 35.6%. The mITT population included all patients to undergo at least one post-baseline efficacy evaluation.

These data highlight that the efficacy and safety of a single administration of Cx601 were maintained during one year of follow up, TiGenix CMO. Marie Paule Richard said in a statement. It is important to also note that the definition of combined remission used in the ADMIRE-CD study, which includes both clinical and radiological assessment by MRI, is more stringent than the criteria commonly used in previous large scale, randomized clinical trials evaluating perianal fistulas in Crohns disease, based only on clinical assessment.

Relapse rates in the Cx601 group were rarer, too. Three-quarters of participants who responded to Cx601 after 24 weeks made it to 52 weeks without relapsing. The number falls to 55.9% among the placebo cohort.

TiGenix is hoping the data will prove compelling enough to secure a regulatory approval in Europe later this year. In parallel, TiGenix is setting up another phase 3 trial designed to deliver data to support approval in the U.S.. TiGenix expects the trial to start later this year.

Shares in TiGenix traded up 4% shortly after the stock exchange in Brussels opened for the day.

See the original post:
Takeda, TiGenix stem cell therapy shows sustained effect - FierceBiotech

Read More...

Stem cell therapy treatment gives new lease of life to 5-year-old – Avenue Mail

Friday, February 17th, 2017

Stem cell therapy treatment gives new lease of life to 5-year-old Jamshedpur February 17, 2017 , by Desk 60

Ranchi : Till very recently, it was believed that brain damage is irreversible. However, now with emerging research; we understand that it is possible to repair the damaged brain tissue using cell therapy.

Again, today there are still many people in India who have not preserved their stem cells through cord blood banks. For all those patients, who have lost their hopes in finding a new treatment for neurological related disorders, adult stem cell therapy offers a new hope for such kind of patients.

Dr Alok Sharma, Director, NeuroGen Brain and Spine Institute, Professor and Head of Neurosurgery, LTMG Hospital & LTM Medical College, Sion said Stem cell therapy is emerging as one of the newer treatment options for conditions like Autism, Cerebral Palsy, Mental retardation, Muscular Dytrophy, Spinal Cord Injury, Paralysis, Brain Stroke, Cerebellar Ataxia and Other Neurological Disorders. This treatment has the potential to repair the damaged neural tissue at molecular, structural and functional level.

Dr. NandiniGokulchandran, Deputy Director, Neurogen Brain and Spine Institute saidStem Cell Therapy (SCT) done at NeuroGen Brain and Spine Institute is a very simple and safe procedure. Stem Cells are taken from patients own bone marrow with the help of one needle and are injected back in their Spinal Fluid after processing.

Since they are taken from the patients own body there is no rejection, no side effects, hence making SCT a completely safe procedure.

Today, we are presenting a case study of Ranchi based 5 yrs old Master Dhairya Singh. He is a known case of brain damage due to lack of oxygen but not during birth. Dhairya was born in a normal manner, cried immediately after birth also his birth weight was appropriate.

There were no immediate post-natal complications reported. Dhariya was a normal child till the age of one and half years old. Then one day he suffered from an episode of pneumonia for which he was hospitalized for 6 days.

Last updated:Friday, February 17, 2017

Previous Article Rungta Mines launches computer literacy course

Next Article Jharkhand to see investment worth Rs 55K crore in highways in next 30 months: Gadkari

Read more:
Stem cell therapy treatment gives new lease of life to 5-year-old - Avenue Mail

Read More...

A.J. Foyt planning to undergo stem cell therapy | USA TODAY Sports – USA TODAY

Wednesday, February 15th, 2017

USA TODAY
A.J. Foyt planning to undergo stem cell therapy | USA TODAY Sports
USA TODAY
Auto racing legend A.J. Foyt is hoping to find the fountain of youth for a body that has taken quite a beating over the years. And like a handful of athletes before ...

and more »

Read the rest here:
A.J. Foyt planning to undergo stem cell therapy | USA TODAY Sports - USA TODAY

Read More...

Paralyzed Easton Teen Seeking Stem Cell Treatment In Bid To Move Legs Again – Brookfield Daily Voice

Wednesday, February 15th, 2017

EASTON, Conn. --Hope is a big word in the Standen household in Easton these days.

Through a procedure at the Cell Medicine Institute in Panama, there is a 60 percent to 70 percent chance that Zach Standen a 17-year-old who became paralyzed from the waist down after a car accident last summer may regain some feeling and movement in his legs.

In the procedure, The stem cells are taken from your own bone marrow and human umbilical cords and are re-injected into your body," Zachs mother, Christine Standen, said in a phone interview.

The ultimate goal is for the stem cells from Zach's body to regenerate the nerves and neural connections for him to regain some feeling and function in his legs.

It's extremely important that Zach gets the treatment as soon as possible, his mother said. "He should get the stem cell therapy within a year of the accident since this is when the most healing occurs and before scar tissue is laid down," Christine Standen said. Once this happens, she said, muscle mass is lost and muscles begin to atrophy.

Related story: Easton teen is left paralyzed after car crash.

Zach's family has set up a GoFundMe page to raise the nearly $40,000 needed to pay for the treatment. So far, the page has been shared 687 times. With 313 donations, it has raised $18,194 out of a $100,000 goal.

The family is hoping to raise enough money to get Zach two stem cell treatments, which would greatly increase his chances for recovery.

In addition, a fundraiser has been established to benefit the cause for Zach. Through Feb. 28, a total of 15 percent of the cost of the Arbonne products from this page will be donated to Zach Standens Stem Cell Therapy Fund.

Zach and his mother, as well as Zachs girlfriend, Constance Rude, plan on taking the month-long trip to Panama.

We are hoping that Zach [who attends Joel Barlow High School in Redding] will get his homework assignments ahead of time," she said, adding that he will most likely have to take summer classes or make up some timein the fall.

In a post on Zachs GoFundMe Page, his mother wrote, As of right now, there has been very little progress physically and I can't see him being like this for the rest of his life. No walking, no bowel or bladder control, no sexual function, no feeling. This is no way to live if we can help it, especially for a 17 year old."

She said Zach's spirits are waning. "He is finding it difficult to study and is trying to maintain hope."

Aside from his medical issues, Zach has the life of a typical teenager he goes to school and hangs out with his friends.

Related story: A family seeks support for treatment for paralyzed son.

Zach goes twice a week to physical therapy at Gaylord Hospital in Wallingford. "He is working really hard, every day," said his mother.

Another fundraiser for Zachwill be a concert by the Grayson Hugh & The Moon Hawks & The Bobby Paltauf Band on March 11 at 7 p.m. at the Fairfield Theatre Company. A total of 25 percent of ticket sales will go toward Zach's Stem Cell Therapy Fund.

Christine Standen said she feels extreme gratitude toward for the support the family has received through this tough time. "We are so grateful to the entire community," she said.

For previous Daily Voice articles on Zach Standen, click here and here .

See the article here:
Paralyzed Easton Teen Seeking Stem Cell Treatment In Bid To Move Legs Again - Brookfield Daily Voice

Read More...

Paralyzed Easton Teen Seeking Stem Cell Treatment In Bid To … – Wilton Daily Voice

Wednesday, February 15th, 2017

EASTON, Conn. --Hope is a big word in the Standen household in Easton these days.

Through a procedure at the Cell Medicine Institute in Panama, there is a 60 percent to 70 percent chance that Zach Standen a 17-year-old who became paralyzed from the waist down after a car accident last summer may regain some feeling and movement in his legs.

In the procedure, The stem cells are taken from your own bone marrow and human umbilical cords and are re-injected into your body," Zachs mother, Christine Standen, said in a phone interview.

The ultimate goal is for the stem cells from Zach's body to regenerate the nerves and neural connections for him to regain some feeling and function in his legs.

It's extremely important that Zach gets the treatment as soon as possible, his mother said. "He should get the stem cell therapy within a year of the accident since this is when the most healing occurs and before scar tissue is laid down," Christine Standen said. Once this happens, she said, muscle mass is lost and muscles begin to atrophy.

Related story: Easton teen is left paralyzed after car crash.

Zach's family has set up a GoFundMe page to raise the nearly $40,000 needed to pay for the treatment. So far, the page has been shared 687 times. With 313 donations, it has raised $18,194 out of a $100,000 goal.

The family is hoping to raise enough money to get Zach two stem cell treatments, which would greatly increase his chances for recovery.

In addition, a fundraiser has been established to benefit the cause for Zach. Through Feb. 28, a total of 15 percent of the cost of the Arbonne products from this page will be donated to Zach Standens Stem Cell Therapy Fund.

Zach and his mother, as well as Zachs girlfriend, Constance Rude, plan on taking the month-long trip to Panama.

We are hoping that Zach [who attends Joel Barlow High School in Redding] will get his homework assignments ahead of time," she said, adding that he will most likely have to take summer classes or make up some timein the fall.

In a post on Zachs GoFundMe Page, his mother wrote, As of right now, there has been very little progress physically and I can't see him being like this for the rest of his life. No walking, no bowel or bladder control, no sexual function, no feeling. This is no way to live if we can help it, especially for a 17 year old."

She said Zach's spirits are waning. "He is finding it difficult to study and is trying to maintain hope."

Aside from his medical issues, Zach has the life of a typical teenager he goes to school and hangs out with his friends.

Related story: A family seeks support for treatment for paralyzed son.

Zach goes twice a week to physical therapy at Gaylord Hospital in Wallingford. "He is working really hard, every day," said his mother.

Another fundraiser for Zachwill be a concert by the Grayson Hugh & The Moon Hawks & The Bobby Paltauf Band on March 11 at 7 p.m. at the Fairfield Theatre Company. A total of 25 percent of ticket sales will go toward Zach's Stem Cell Therapy Fund.

Christine Standen said she feels extreme gratitude toward for the support the family has received through this tough time. "We are so grateful to the entire community," she said.

For previous Daily Voice articles on Zach Standen, click here and here .

See original here:
Paralyzed Easton Teen Seeking Stem Cell Treatment In Bid To ... - Wilton Daily Voice

Read More...

Local stem cell researcher to appear on Dr. Oz today – Albany Times Union

Wednesday, February 15th, 2017

From left are Dr. Oz, researcher Sally Temple, patient Patricia Holman, television personality Montel Williams and Dr. Elisabeth Leamy. (Courtesy Sony Pictures Television)

From left are Dr. Oz, researcher Sally Temple, patient Patricia Holman, television personality Montel Williams and Dr. Elisabeth Leamy. (Courtesy Sony Pictures Television)

From left are Dr. Oz, researchers Sally Temple, patient Patricia Holman, Dr. Elisabeth Leamy and television personality Montel Williams. (Courtesy Sony Pictures Television)

From left are Dr. Oz, researchers Sally Temple, patient Patricia Holman, Dr. Elisabeth Leamy and television personality Montel Williams. (Courtesy Sony Pictures Television)

Dr. Oz with Sally Temple, scientific director and co-founder of the Neural Stem Cell Institute. (Courtesy Sony Pictures Television)

Dr. Oz with Sally Temple, scientific director and co-founder of the Neural Stem Cell Institute. (Courtesy Sony Pictures Television)

Local stem cell researcher to appear on Dr. Oz today

Sally Temple has a plea for people considering stem cell therapy to cope with a chronic illness or life-threatening disease: Don't. Not yet.

Temple, co-founder of the Neural Stem Cell Institute in Rensselaer and president of the International Society for Stem Cell Research, has spent her career studying stem cells. Her pre-taped appearance on "The Dr. Oz Show" airs Tuesday, Feb. 14, where she talks about the difference between stem cell research and what she calls the "snake oil" promises of clinics that haven't been approved by the FDA but promise miracle cures for scourges like Alzheimer's and Parkinson's diseases.

Stem cells hold promise for treatment because they are the foundation from which all parts of the human body grow.

There are more than 500 clinics in the country offering unproven therapies, including some in New York state and a lot in Florida. "We know it's going on all around the world," Temple said.

Patients lured by false promises spend a lot of money. Temple said people have taken out second mortgages to cover the costs. But they are also at medical risk, Temple said, because injecting stem cells even the patient's own cells can have unpredictable results.

On TV

The Dr. Oz Show airs at 2 p.m. weekdays on NewsChannel 13 WNYT. Learn more about stem cell research at http://neuralsci.org.

"We're now hearing of people getting dreadful outcomes, tumors and blindness," she said.

It's because, without FDA approval and the long process of testing a new drug, there's no way to know for sure what's in the syringe, Temple said. "It may sound good to take stem cells from your own fat and inject them into your eye, but injecting stem cells that were good at making fat into another part of the body where they were never supposed to be can be disastrous."

Dr. Mehmet Oz said he chose this subject because there are stem cell clinics using the potential of legitimate research to take advantage of patients desperate for help.

"These physicians are violating not only the trust of their patients but also the law and hopefully our show will push the FDA to use its authority to shut them down," Oz said.

Temple said she was impressed by how informed Oz was during the taping for the show in New York City last month, and said it was clear the researchers and producers on the show had done their homework. Montel Williams, a former show host himself, also appeared on the segment. Williams suffers from multiple sclerosis and said he's been approached by clinics who want his celebrity endorsement.

"He was fully aware of lack of research and knew that when you dig for scientific rationale, it's not there," Temple said. "True stem cell therapy is coming, but we have to go through the proper channels and know it's safe."

Go here to read the rest:
Local stem cell researcher to appear on Dr. Oz today - Albany Times Union

Read More...

Paralyzed Easton Teen Seeking Stem Cell Treatment In Bid To Move Legs Again – New Canaan Daily Voice

Tuesday, February 14th, 2017

EASTON, Conn. --Hope is a big word in the Standen household in Easton these days.

Through a procedure at the Cell Medicine Institute in Panama, there is a 60 percent to 70 percent chance that Zach Standen a 17-year-old who became paralyzed from the waist down after a car accident last summer may regain some feeling and movement in his legs.

In the procedure, The stem cells are taken from your own bone marrow and human umbilical cords and are re-injected into your body," Zachs mother, Christine Standen, said in a phone interview.

The ultimate goal is for the stem cells from Zach's body to regenerate the nerves and neural connections for him to regain some feeling and function in his legs.

It's extremely important that Zach gets the treatment as soon as possible, his mother said. "He should get the stem cell therapy within a year of the accident since this is when the most healing occurs and before scar tissue is laid down," Christine Standen said. Once this happens, she said, muscle mass is lost and muscles begin to atrophy.

Related story: Easton teen is left paralyzed after car crash.

Zach's family has set up a GoFundMe page to raise the nearly $40,000 needed to pay for the treatment. So far, the page has been shared 687 times. With 313 donations, it has raised $18,194 out of a $100,000 goal.

The family is hoping to raise enough money to get Zach two stem cell treatments, which would greatly increase his chances for recovery.

In addition, a fundraiser has been established to benefit the cause for Zach. Through Feb. 28, a total of 15 percent of the cost of all Arbonne products will be donated to Zach Standens Stem Cell Therapy Fund.

Zach and his mother, as well as Zachs girlfriend, Constance Rude, plan on taking the month-long trip to Panama.

We are hoping that Zach [who attends Joel Barlow High School in Redding] will get his homework assignments ahead of time," she said, adding that he will most likely have to take summer classes or make up some timein the fall.

In a post on Zachs GoFundMe Page, his mother wrote, As of right now, there has been very little progress physically and I can't see him being like this for the rest of his life. No walking, no bowel or bladder control, no sexual function, no feeling. This is no way to live if we can help it, especially for a 17 year old."

She said Zach's spirits are waning. "He is finding it difficult to study and is trying to maintain hope."

Aside from his medical issues, Zach has the life of a typical teenager he goes to school and hangs out with his friends.

Related story: A family seeks support for treatment for paralyzed son.

Zach goes twice a week to physical therapy at Gaylord Hospital in Wallingford. "He is working really hard, every day," said his mother.

Another fundraiser for Zachwill be a concert by the Grayson Hugh & The Moon Hawks & The Bobby Paltauf Band on March 11 at 7 p.m. at the Fairfield Theatre Company. A total of 25 percent of ticket sales will go toward Zach's Stem Cell Therapy Fund.

Christine Standen said she feels extreme gratitude toward for the support the family has received through this tough time. "We are so grateful to the entire community," she said.

For previous Daily Voice articles on Zach Standen, click here and here .

Originally posted here:
Paralyzed Easton Teen Seeking Stem Cell Treatment In Bid To Move Legs Again - New Canaan Daily Voice

Read More...

Educational seminar on stem cell therapy to be featured at lunch meeting in Abilene – Salina Post

Monday, February 13th, 2017

Kansas Regenerative Medicine Center (KRMC) staff will be the guest speakers at the next Healthwise 55 luncheon. Speakers Frank Lyons, MD; John Farley (Founder); and Kate Farley will define stem cells and explain their many therapeutic uses. The KRMC staff will also share how stem cell therapy is a potential alternative to joint replacements or other medical therapies.

The event will be on Thursday, February 23, from noon to 1 p.m. in the Conklin Conference Center at Memorial Hospital, located at 511 N.E. 10th, Abilene. The cost is $5.00 to cover the price of the meal. Please call Michelle McClanahan, MHS Director of Volunteer Services, at (785) 263-6692 by Monday, February 20, to make a reservation.

Healthwise 55 is a luncheon and health information program hosted by the MHS Volunteer Corps. It is open to the public for individuals ages 55 and older. It includes a meal followed by a health care professional(s) speaking on a health-related topic.

Read this article:
Educational seminar on stem cell therapy to be featured at lunch meeting in Abilene - Salina Post

Read More...

‘Economical stem cell treatment will revolutionise medicine’ – The Hindu

Friday, February 10th, 2017

Cost-effective stem cell treatment has to be the next revolution to transform personalised treatment of patients, said Hunterian Professorship Awardee A.A.Shetty. Speaking at a felicitation function, Dr. Shetty said there is a need to create awareness about stem cells and patient-specific treatment specifically designed for individuals.

It is going to be simple, with minimal complications. Our role is to make it cost effective. Once it happens, it will revolutionise treatment, said Dr. Shetty.

Surgery using stem cell technology is developing at a rapid pace and the role of stem cell therapy in Orthopaedics is gaining importance, said Trauma and Orthopaedic Speciality Hospital (TOSH) Managing Director S.H. Jaheer Hussain. The ability of stem cells to transform into bone and cartilage has given a new dimension in the treatment of osteoarthritis, fracture non union, ligament tears. Stem cells have shown significant clinical results in osteoarthritis and cartilage defects. Recent advances in stem cells centrifuging techniques have lead to the introduction of the new concept of single- stage knee cartilage regeneration.

Continue reading here:
'Economical stem cell treatment will revolutionise medicine' - The Hindu

Read More...

SEQUEIRA: Stem cell research must remain in foreground – University of Virginia The Cavalier Daily

Thursday, February 9th, 2017

OPINION Where will studies fall in the Trump administrations line of immediacy? by Sean Sequeira | Feb 09 2017 | 12 hours ago | Updated 13 hours ago

As President Trumps cabinet ossifies into its final form, several Americans predict that many policy consistencies of the past are now at risk. One place of consistency is the landscape of stem cell research. The impacts Trumps administration might have on biomedical science are still uncertain. Indeed, some cabinet appointments have incited fear in Americans who rely on stem cell therapy or perform research or work at institutions where stem cell research is a vital component of grants and general revenue. While uniformly and staunchly conservative, the Trump administration must ensure continuity within stem cell research not only to protect jobs and research institutions from bankruptcy, but to also preserve a therapy that might actually be a panacea for a range of maladies.

Stem cells, while controversial and ethically precarious to the public, should be researched and ultimately implemented as a therapeutic solution for patients that simply have no alternative. Specifically, stem cells opponents are against embryonic stem cells, which no longer account for the majority of stem cell research. Currently, the majority of stem cell research is made up of induced pluripotent stem cells, somatic cells which can regress to an embryonic state through regenerative and genetic engineering. With the seminal work of Drs. Takahash and Yamanaka, the ethical rigors associated with embryonic stem cells need not be dealt with.

However, the question arises as to why embryonic stem cells are so insatiably invaluable and why they have immense potential to solve the worlds most enigmatic medical maladies. Indeed, after a zygote forms, the subsequent cells follow a pathway based upon environmental and biological cues similar to how a student follows a pathway to become a doctor, lawyer or businessman. Stem cells are categorized according to the broadness of cell they can become embryonic stem cells are the most versatile whereas adult stem cells, like those found in your bone marrow, are comparatively discrete in their differentiation scope. So, with embryonic stem cells, appropriate cues, and research, we could theoretically program these stem cells to become a pancreas, heart, brain or liver cells. On a macroscale, stem cells provide a conduit through which to build full pancreases for diabetic patients or hearts for heart failure patients, from the ground up. Essentially, with stem cells, we can turn the tide in a seemingly perennial battle with virulent pathologies.

Induced pluripotent stem cells, or iPSCs, are actually adult somatic cells like those found on your skin which revert back to their embryonic state through transcription factors or proteins necessary to develop or progress the fate or state of a cell to a new state. In this case, the Yamanaka factors are four transcription factors are those necessary to combine with adult somatic cells in order to revert the cells back into embryonic stem cells.

Granted, while the discovery of iPSC was a phenomenal one, there is a long road ahead in order to make them a mainstream therapy and to ensure that they are morphologically, molecularly, and functionally identical to their embryonic counterparts. During the Obama administration, research institutions like the National Institute of Health were not only provided the opportunity to research using stem cells, but were also less impeded than they were during the George W. Bush administration in the quantity and quality of research they were able to undertake.

With the new administration, it has become necessary that they scrap their conservative agenda against stem cells and biomedical research by demonstrating to the public they care and see their constituents as people in need of stem cell research. The administration must recognize the ultimate way to defeat unscrupulous stem cell utilization is to fund research to find novel ways to circumvent such controversy.

Sean Sequeira is an Opinion columnist for the Cavalier Daily. He can be reached at s.sequeira@cavalierdaily.com

Read more:
SEQUEIRA: Stem cell research must remain in foreground - University of Virginia The Cavalier Daily

Read More...

Experimental stem cell therapy brings positive results – Manufacturer.com

Wednesday, February 8th, 2017

Kris Boesen works out his upper body after being part of a new stem cell trial. Image courtesy of Greg Iger

USC researchers have potentially discovered the secret to treating paraplegic injuries using stem cells.

A team of doctors from the Keck Medical Center of USC have become the first in California to inject a patient with an experimental treatment made from stem cells as part of a multi-center clinical trial.

The patient in question is Kristopher (Kris) Boesen, a 21-year-old who on March 6 last year suffered a traumatic injury to his cervical spine after his car fishtailed on a wet road and slammed into both a tree and telephone pole.

Kris parents were told that there was a good chance their son would be permanently paralyzed from the neck down. That was until the Keck Medical Center of USCs surgical team offered them hope in the form of an injection of an experimental dose of 10 million AST-OPC1 cells directly into Kris cervical spinal cord just one month after his accident.

Now nine months after this injection and Kris is one of six patients to have lost all motor and sensory function below the injury site that have shown additional motor function improvement after both six months and nine months of treatment with 10 million AST-OPC1.

The stem cell procedure received by the six patients is part of a Phase 1/2a clinical trial which is evaluating the safety and efficacy of escalating doses of AST-OPC1 cells developed by biotechnology company Biotherapeutics Inc.

The positive efficacy results from this study and the effect it has had on the five patients were announced on January 24 at a press conference held by Biotherapeutics Inc.

The positive results in regards to improvements in upper extremity motor function were measured using the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) scale. The trial saw improvements in Upper Extremity Motor Score and also Motor Level Improvement amongst the six patients.

For the five patients who completed at least six months of follow-up, all five patients saw early improvements in their motor score (UEMS) at three months maintained or further increased through their most recent data point of either six or nine months.

And for patients completing at least six months of follow-up, all five achieved at least one motor level improvement over baseline on at least one side, and two of the five had achieved two motor levels over baseline on at least one side, while one patient achieved a two motor level improvement on both sides.

The trial results reveal a positive safety profile for AST-OPC1, as there have been no serious adverse events from the study which indicates that AST-OPC1 can be safely administered to patients in the subacute period after severe cervical spinal cord injury.

Dr Richard Fessler is the professor in the department of neurosurgery at Rush University Medical Center, one of six centers in the US currently studying this new stem cell treatment.

Dr Fessler said the new treatment was bringing improvements to the patients lives involved in the trial: With these patients, we are seeing what we believe are meaningful improvements in their ability to use their arms, hands and fingers at six months and nine months following AST-OPC 1 administration.

Recovery of upper extremity motor function is critically important to patients with complete cervical spinal cord injuries, since this can dramatically improve quality of life and their ability to live independently.

Read more:
Experimental stem cell therapy brings positive results - Manufacturer.com

Read More...

The next weapon against brain cancer may be human skin – The Verge

Tuesday, February 7th, 2017

Human skin can be morphed into genetically modified, cancer-killing brain stem cells, according to a new study. This latest advance has only been tested in mice but eventually, its possible that it could be translated into a personalized treatment for people with a deadly form of brain cancer.

The study builds on an earlier discovery that brain stem cells have a weird affinity for cancers. So researchers, led by Shawn Hingtgen, a professor at University of North Carolina at Chapel Hill, created genetically engineered brain stem cells out of human skin. Then they armed the stem cells with drugs to squirt directly onto the tumors of mice that had been given a human form of brain cancer. The treatment shrank the tumors and extended survival of the mice, according to results recently published in the journal Science Translational Medicine.

The treatment shrank the tumors and extended survival

Usually we think about stem cell therapy in the context of rebuilding or regrowing a broken body part like a spinal cord. But if they could be modified to become cancer-fighting homing missiles, it would give patients with a deadly and incurable brain cancer called glioblastoma a better chance at survival. Glioblastomas typically affect adults, and are highly fatal because they send out a web of cancerous threads. Even when the main mass is removed, those threads remain despite chemotherapy and radiation treatment. This cancer has caused a number of high-profile deaths including Senator Edward (Ted) Kennedy in 2009, and possibly Beau Biden more recently. Approximately 12,000 new cases of glioblastoma are estimated to be diagnosed in 2017.

We really have no drugs, no new treatment options in years to even decades, Hingtgen says. [We] just really want to create new therapy that can stand a chance against this disease.

But theres a problem: brain stem cells arent exactly easy to get. Brain stem cells, more properly known as neural stem cells, hang out in the walls of the brains irrigation canals areas filled with cerebrospinal fluid, called ventricles. They generate the cells of the nervous system, like neurons and glial cells, throughout our lives.

They could be modified to become cancer-fighting homing missiles

A research group at the City of Hope in California conducted a clinical trial to make sure it was safe to treat glioblastoma patients with genetically engineered neural stem cells. But they used a neural stem cell line that theyd obtained from fetal tissue. Since the stem cells werent the patients own, people who were genetically more likely to reject the cells couldnt receive the treatment at all. For the people who could, treatment with the neural stem cells turned out to be relatively safe although at this phase of clinical trials, it hasnt been particularly effective.

More personalized treatments have been held up by the challenge of getting enough stem cells out of the patients own brains, which is virtually impossible, says stem cell scientist Frank Marini at the Wake Forest School of Medicine, who was not involved in this study. You cant really generate a bank of neural stem cells from anybody because you have to go in and resect the brain.

So instead, Hingtgen and his colleagues figured out a way to generate neural stem cells from skin which in the future, could let them make neural stem cells personalized to each patient. For this study, though, Hingtgen and his colleagues extracted the skin cells from chunks of human flesh leftover as surgical waste. That really is the magic piece here, Marini says. Now, all of a sudden we have a neural stem cell that can be used as a tumor-homing vehicle.

That really is the magic piece here.

Using a disarmed virus to infect the cells with a cocktail of new genes, the researchers morphed the skin cells into something in between a skin cell and a neural stem cell. People have turned skin cells back into a more generalized type of stem cell before. But then turning those basic stem cells into stem cells for a certain organ like the brain takes another couple of steps, which takes more time. Thats something that people with glioblastoma dont have.

The breakthrough here is that Hingtgens team figured out how to go straight from skin cells to something resembling a neural stem cell in just four days. The researchers then genetically engineered these induced neural stem cells to arm them with one of two different weapons: One group was equipped with an enzyme that could convert an anti-fungal drug into chemotherapy, right at the cancers location. The other was armed with a protein that binds to the cancer cells and makes them commit suicide in an orderly process called apoptosis.

The researchers tested these engineered neural stem cells in mice that had been injected with human glioblastoma cells, which multiplied out of control to create a human cancer in a mouse body. Both of the weaponized stem cell groups were able to significantly shrink the tumors and keep the mice alive by about an extra 30 days (for scale, mice usually live an average of two years).

Were working as fast as we can.

But injecting the cells directly into the tumor doesnt really reflect how the therapy would be used in humans. Its more likely that a person with glioblastoma would get the bulk of the tumor surgically removed. Then, the idea is that these neural stem cells, generated from the patients own skin, will be inserted into the hole left in the brain. So, the researchers tried this out in mice, and the tumors that regrew after surgery were more than three times smaller in the mice treated with the neural stem cells.

Its a promising start, but it could take a few years still before its in the clinic, Hingtgen says. He and his colleagues started a company called Falcon Therapeutics to drive this new therapy forward. Were working as fast as we can, Hingtgen says. We probably cant help the patients today. Hopefully in a year or two, well be able to help those patients.

One of the things theyll have to figure out first is whether the neural stem cells can travel the much bigger distances in human brains, and whether theyll be able to eliminate every remaining cancer cell. The caveats on this are that, of course, its a mouse study, and whether or not that directly converts to humans is unclear, Marini says. Still, he adds, Theres a very high probability in this case.

View original post here:
The next weapon against brain cancer may be human skin - The Verge

Read More...

Stem Cell Therapy Helps North Texas Teen Beat Asthma | NBC 5 … – NBC 5 Dallas-Fort Worth

Monday, February 6th, 2017

A North Texas teenager who battled severe asthma for years is breathing free and clear again after doctors used stem cell therapy to temporarily treat his condition. (Published Monday, Jan. 30, 2017)

A North Texas teenager who battled severe asthma for years is breathing free and clear again after doctors used stem cell therapy to temporarily treat his condition.

Kenton Crenshaw, 18, of Crowley, never knew when his asthma would strike.

"Like 2, 3, 4 in the morning and it just hits me and I freak out," Crenshaw said.

"My asthma stopped me from doing lots of stuff that I wanted to do," he added.

Activity, even as light as walking outside, came with risk.

"I spent eight Christmases in the hospital because of asthma days or weeks long, birthdays it's just controlled my life," he said.

Crenshaw took countless medications but nothing seemed to help, so his family brought him to Dr. Bill Johnson at Innovations Medical in Dallas.

Johnson is one of a growing group of doctors using stem cell therapy to treat various diseases.

"The stem cells have the ability to reproduce and become other types of tissue, and that's what makes them so special," Johnson said.

Johnson took a small amount of fat from the Crenshaw through liposuction and separated the stem cells in a centrifuge.

He then mixes the stem cells with a solution, which is given back to patients, like Crenshaw, through intravenous therapy or breathing treatments.

"He has an overactive immune system with his lungs and airways, and what the stem cells can do is turn that down, decrease inflammation, and he's had a remarkable course," Johnson said, of Crenshaw.

It's been a few months since the treatments, and Crenshaw says he hasn't needed many of his medications.

"I felt like I never had asthma, like I feel perfect. I didn't do one breathing treatment in almost three months and I used to do four to six breathing treatments a day," he said.

The treatment isn't said to cure his asthma, but the results can last a year possible longer.

"I hope I never have an asthma attack the rest of my life," Crenshaw said.

Stem cell therapy treatments cost upwards of $7,000 and are not covered by insurance.

Published at 10:03 PM CST on Jan 30, 2017 | Updated at 10:41 PM CST on Jan 30, 2017

Originally posted here:
Stem Cell Therapy Helps North Texas Teen Beat Asthma | NBC 5 ... - NBC 5 Dallas-Fort Worth

Read More...

Experimental Stem Cell Therapy Stops Multiple Sclerosis In Its … – Vocativ

Monday, February 6th, 2017

The prognosis for people affected by multiple sclerosis (MS), a degenerative autoimmune disorder that decimates the central nervous system, is a bleak one. The disease oftenbegins with a sudden burst of neurological symptoms like muscle spasms, vision problems, and trouble walking, then progresses differently, depending on which form of MS someone has. But eventually, nearly everyone with the disease comesto the point of being unable to move, breathe, or live independently. And sufferers on average live anywhere from five to ten years less than the general public.

Currently, the best medications we have available do little more than slow MS down, or tamp down peoples symptoms. But an experimental therapy continues to provide the first glimmers of something ground-breaking an actual way to stop one form of the disease in its tracks, and maybe even reverse some of the damage already done.

In this months Neurology, researchers detailed the final five-year-old results of a small clinical trial called HALT-MS. Twenty-four volunteers with MS who hadnt responded to conventional drugs were first given a powerful form of chemotherapy, high-dose immunosuppressive therapy (HDIT), that wiped out their immune system. Then they were given a transplant of their own stem cells taken out earlier, known as autologous hematopoietic cell transplant (HCT). These purified cells, the researchers theorized, would seed a new generation of uncorrupted white blood cells and reset the immune system, freezing MS in its place.

For the most part thats exactly what the combination HDIT/HCT therapy did. Nearly 70 percent of patients, five years in, have experienced no signs of the disease progressing. They havent had a relapse of symptoms, become more disabled, or had new brain lesions show up in imaging exams. Some have actually improved physically in the years since the treatment. And even those not in complete remission appear to be suffering less than before. Importantly, though the treatment isnt free of side-effects, there havent been severe ones. There were three deaths seen during the trial, all of whom experienced worsening MS, but none were attributed to the treatment.

The volunteers all had relapsing-remitting MS, the most common form, in which symptoms come and go with little rhyme or reason.

The evidence at this time is encouraging, but it isnt definitive, study author Dr. Linda Griffith, a researcher at the National Institute of Allergy and Infectious Diseases (NIAID), which sponsored the study, told Vocativ.

As Vocativ has previously reported, this isnt the first trial to find similar success rates for HDIT/HCT, though it does come with its own dangers. Patients can die from it, and like all kinds of chemotherapy, the deliberate weakening of the immune system often leads to more infections. It also doesnt seem to be as effective for more advanced types of MS, when the disease has stopped causing active inflammation, said Griffith. And while it could be promising for people in the earliest stages of MS, the research needed to promote it as a first-line treatment isnt there yet either, she added.

For now, the only trials of HDIT/HCT have been small and isolated. And though the effects of it when successful seem to extend as far out as 13 years later, its too early to call it a full-on cure. We still dont have a clear grasp of why MS happens in the first place, but its thought that multiple triggers like infections and unlucky genetics combine to increase peoples risk. So even if resetting someones immune system does treat MS completely, its plausible that some percentage of patients could fall victim to it again down the road, Griffith explained. We just dont know enough right now.

But Griffith is hopeful that larger, randomized studies will be underway within the next year or so. And if those prove to be as successful as the HALT-MS trial and others, the therapy could someday soon lead to a light at the end of tunnel for the millions of MS sufferers alive today.

Excerpt from:
Experimental Stem Cell Therapy Stops Multiple Sclerosis In Its ... - Vocativ

Read More...

Stem Cell Therapy Offers Hope to Multiple Sclerosis Patients (VIDEO) – Newsy

Monday, February 6th, 2017

ByEthan Weston February 2, 2017

Stem cell research is making medical breakthroughs, and now, it could offer hope to people who have multiple sclerosis.

A newNational Institutes of Healthstudy suggests one-time stem cell transplants might be more effective than long-term medicinal treatment at treating relapsing-remitting MS.

Multiple sclerosis is an autoimmune disease that causes a person's immune system to attack their central nervous system. Common symptoms are impaired motor function, weakness and chronic pain. Relapsing-remitting MS is the most common form of the disease.

Stem cells are cells that haven't decided what they want to be when they grow up. That means they can develop into different types of cells. Because of that, they can be used to heal older damaged cells, like those attacked by the immune system.

The study followed 24 people who weren't having success with the typical MS medications. The experimental treatment suppressed participants' immune systems with chemotherapy. Then, their own stem cells were transplanted back into their bodies to rebuild their immune systems.

Related StoryPart-Pig, Part-Human Embryos Could Give Us Replacement Human Organs

Five years after treatment, most participants' symptoms were in remission. Some of them even showed some improvements.

Larger studies will be needed to confirm these findings. But the head of the study said it's a good first step toward more effective treatment for an incredibly debilitating and deadly disease.

Read the rest here:
Stem Cell Therapy Offers Hope to Multiple Sclerosis Patients (VIDEO) - Newsy

Read More...

From Down syndrome to ‘near normal’? New Delhi clinic makes stem cell claims that worry experts – National Post

Monday, February 6th, 2017

A New Delhi clinic that has claimed to help paralyzed Canadians walk again by injecting them with stem cells now says it can use the same treatment to make children with Down syndrome almost near normal.

Nutech Mediworld says it has treated up to 16 newborns, toddlers and older children with Down syndrome. According to its medical director, Geeta Shroff, we have seen that patients actually start improving clinically they become almost at par for their age.

Canadian experts say the bold claim risks raising false expectations and public confusion, much like the now-discredited Liberation therapy for multiple sclerosis, and that its playing off the over-hyped belief stem cells have the potential to cure almost anything.

Its also the latest controversy over stem cell tourism, and the growing number of clinics worldwide marketing pricey, unregulated and unproven treatments.

Nutech Mediworld charges US$5,000 to $6,000 per week for its stem cell-based therapies. The clinic says it has treated such incurable conditions as spinal cord injury and cerebral palsy. Around 20 Canadians have sought treatment at the clinic for paralyzing spinal cord injuries, spending upwards of $US48,000 each. Shroff says some of her patients have regained the ability to walk with walkers.

More recently, she began working with Down syndrome, one of the most common chromosomal disorders worldwide.

Most cases are caused by a random error in cell division. The child ends up with three copies of chromosome 21, instead of the usual two.

That extra copy causes abnormal neuronal development and changes in the central nervous system, Shroff says, leading to persistent developmental delays.

Human embryonic stem cells injected into a childs muscles and bloodstreamcan regenerate and repair that damaged brain, she says. They also work at the genetic level, she claims.

In a single case published last year, Shroff reported treating a two-month-old baby boy in September 2014 diagnosed with Down syndrome at birth. The infant had delayed milestones, lack of speech, subnormal understanding and subnormal motor skills, she wrote.

After two stem cell therapy sessions, the baby started babbling and crawling, she reported. He had improved muscle tone. He was social and was able to recognize near ones.

The child became almost as near normal as possible cognitively

The child became almost as near normal as possible cognitively, Shroff told the Post in an interview. Today, hes talking; hes walking. He was at par with normal children on analysis.

The former infertility specialist uses embryonic stem cells developed from a single fertilized egg donated by an IVF patient 17 years ago. According to Shroff, We have witnessed no adverse events at all.

The Down syndrome treatments, reported by New Scientist, have raised skepticism and alarm. Its not at all clear what cells shes actually putting in patients, says renowned developmental biologist Janet Rossant, senior scientist at the Hospital for Sick Children Research Institute in Toronto.

By just putting them into the bloodstream theres no way to imagine they could contribute to the right tissues.

Embryonic stem cells can also form teratomas benign tumours and masses composed of lung cells, tufts of hair, teeth, bone and other tissues.

The gold standard for any therapy would be a clinical trial comparing treated with untreated children and vetted through proper regulatory systems that clearly she is not going through, Rossant says.

The Ottawa Hospitals Dr. Duncan Stewart, who is leading the first trial in the world of a genetically enhanced stem cell therapy for heart attack, says theres a remote chance embryonic stem cells could help with Down syndrome. But its a stretch. The injected cells would also likely be rejected and die off with days, he believes. If the cells are disappearing within days, how are they working?

This is a very vulnerable population Theyre very vulnerable to people who are selling hope and have no basis for it

This is a very vulnerable population, Stewart adds. Theyre very vulnerable to people who are selling hope and have no basis for it.

But stem cells have taken on almost mystical appeal.

Theyve become a pop culture phenomenon, says healthy policy expert Timothy Caulfield, of the University of Alberta. The field itself is guilty of making breathless announcements about breakthroughs and cutting edge, he says. And people can market that kind of language.

This kind of nonsense doesnt help.

Email: jskirkey@postmedia.com | Twitter:

Continued here:
From Down syndrome to 'near normal'? New Delhi clinic makes stem cell claims that worry experts - National Post

Read More...

Stem Cell Therapy – Premier Stem Cell Institute

Friday, November 18th, 2016

The Re-Brand Premier Regenerative Stem Cell and Wellness Centers, recently rebranded their business from Premier Stem Cell Institute, in response to expanding locations, technology, and treatments. This move reflects the growth and success this company has undergone recently and goals for the future.

PRSC and Wellness Centers President, Kandace Stolz said, This rebrand is the culmination of the years of work weve put into stem cell medicine. Were growing and healing more patients than we ever have before, this new name reflects those accomplishments and gives us room grow. We are so thrilled for this move and cant wait to do even more for our patients going forward.

Premier Regenerative Stem Cell and Wellness Centers will continue to partner with the NFL Alumni Association and treat current and former professional athletes. PRSC remains dedicated to studying stem cell treatment by collecting and tracking data to further stem cell progress and maximize results for all patients. PRSCs commitment to being a leader in stem cell and regenerative medicine is unwavering and will continue to innovate and learn to heal and improve the quality of life for all patients.

About Premier Regenerative Stem Cell and Wellness Centers: PRSC is the leading research and treatment facility in Colorado, providing innovative medicine and therapies for those in pain by harnessing the bodys own natural healing power of stem cells. As team of cutting-edge medical experts, PRSC is dedicated to treating patients by using their own stem cells to heal, improve quality of life, and battle the acute pain of chronic illnesses. Premier Regenerative Stem Cell and Wellness Center locations include Loveland Colorado, Dallas Texas, St. Louis, Missouri, and Jacksonville, Florida. PRSC has plans to expand to other major cities across the United States in the near future.

See the rest here:
Stem Cell Therapy - Premier Stem Cell Institute

Read More...

Page 31«..1020..30313233..4050..»


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick